BioMed Central Blog

New and improved Impact Factors for BioMed Central journals in 2009 Journal Citation Report

The newly released 2009 edition of Thomson Reuters' Journal Citation Report includes official Impact Factors for 77 BioMed Central journals, 54 of which are new or improved.

Some highlights:

• Genome Biology (IF 6.63) increased its Impact Factor and remains BioMed Central's most highly cited journal.
• BMC Biology (IF 5.64) is now ranked #4 of 73 in the BIOLOGY category.
• BMC Medicine (IF 3.99) climbs to #18 of 132 in MEDICINE, GENERAL & INTERNAL. 
• Five more medical journals in the BMC series received their first Impact Factors:
  • BMC Family Practice (IF 1.71)
  • BMC Medical Genomics (IF 2.66)
  • BMC Medical Informatics and Decision Making (IF 1.90)
  • BMC Medical Research Methodology (IF 2.3)
  • BMC Psychiatry (IF 1.83)
• BMC Plant Biology (IF 3.77) remains in the top 10% of the PLANT SCIENCES category, while Plant Methods (IF 2.98) joins the category in the top 15%.
• Biotechnology for Biofuels (IF 4.12) received an impressive first Impact Factor.
• Breast Cancer Research (IF 5.33) has overtaken its closed-access rival to become the highest ranked breast cancer journal.
• Malaria Journal increased its Impact Factor to 3.00, maintaining its position at #2 in the TROPICAL MEDICINE category.
• Orphanet Journal of Rare Diseases (IF 5.84) experienced a significant gain, taking it to #7 of 92 in the MEDICINE, RESEARCH & EXPERIMENTAL category.
• Parasites & Vectors (IF 2.05) made its debut in the JCR, ranked #11 of 28 in the PARASITOLOGY category.
• Acta Veterinaria Scandinavica (IF 1.00) saw an increased Impact Factor for the 3rd successive year.
• Journal of Neuroinflammation (IF 4.68) and Molecular Neurodegeneration (IF 5.09) both appeared in the top 20% of titles in the NEUROSCIENCES category.

Posted by Matthew Cockerill at 10:02    Comments (4)